1 Event Eli Lilly Investors Must Watch

Eli Lilly's (NYSE: LLY  ) mealtime insulin product Humalog brought in a whopping $2.4 billion last year. This drug comprises more than 10% of the drugmaker's total revenue, but Humalog's longevity could be compromised by an upcoming patent expiration, stiff competition by diabetes specialist Novo Nodisk (NYSE: NVO  ) , and more competition in the future if MannKind (NASDAQ: MNKD  ) can get Afrezza, an ultra-rapid and inhalable insulin, on the market. In this video, health-care analyst Max Macaluso dives into this drug's sales, and breaks down the competitive landscape for investors.

Can Eli Lilly Beat the Patent Cliff?Over the next two years, Eli Lilly will see nearly $0.40 of every $1.00 in sales exposed to generic competition. How does the company plan to respond to this huge patent cliff? Better yet, what does this mean for investors? In a brand new premium report on Eli Lilly, The Motley Fool's top pharmaceuticals analyst delves into everything investors need to know about the stock today. Simply click here now to claim your copy.


Read/Post Comments (1) | Recommend This Article (3)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On February 16, 2013, at 5:19 AM, DannyHaszard wrote:

    Zyprexa Diabetes connection conflict of interest.

    Eli Lilly paid billions in fines for the scam.

    Thousands got diabetes as Zyprexa side effect and have to take Lilly insulin to treat the diabetes that was caused by their Zyprexa.

    Eli Lilly Zyprexa can ruin your Pancreas and make you a type 2 diabetic in just a few months of use.I took it 1996-2000 and now am a diabetic for it.

    'Atypical' antipsychotic Zyprexa is the worst offender of them all.Google Haszard Zyprexa got a page up.

    -Daniel Haszard

Add your comment.

DocumentId: 2259613, ~/Articles/ArticleHandler.aspx, 4/18/2014 4:43:02 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement